Study of 18F-FAPI Applied to Gastrointestinal Cancer

Xi'an Jiaotong University

Status: Not yet enrolling

Conditions: Gastrointestinal Cancer

Treatments: Diagnostic Test: 18F-FAPI and 18F-FDG PET/CT

Study type: Observational

Funder types: Other

Identifiers

NCT05788874

XJTU1AF-CRF-2022-021

Details and patient eligibility

About

Comparison of tumor volume, number, and SUVmax of different primary foci (gastric, duodenal, and colon cancer), lymph node metastases (neck and supraclavicular, mediastinal, abdominal, and pelvic), and distant metastases (brain, lung, liver, bone, pleura, and peritoneum) detected by 18F-FAPI versus 18F-FDG PET/CT imaging.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with high clinical suspicion of gastrointestinal tumor and negative 18F-FDG at first diagnosis
• Post-treatment patients with high clinical suspicion of recurrence or metastasis and negative 18F-FDG

Exclusion criteria

• The diagnosis can be clarified by 18F-FDG PET/CT examination
• The presence of recurrence or metastasis can be clarified by 18F-FDG PET/CT examination

Trial design

50 participants in 2 patient groups

18F-FDG

Treatment:

Diagnostic Test: 18F-FAPI and 18F-FDG PET/CT

18F-FAPI

Treatment:

Diagnostic Test: 18F-FAPI and 18F-FDG PET/CT